Develop new diagnoses and treatment options for congenital heart disease

This grant supports research to provide new diagnoses and treatment options for those suffering from congenital heart disease.

For this grant opportunity:

• $20 million is available over 5 years
• there is no minimum grant amount
• the maximum grant amount is $10 million
• the grant amount can be up to 100% of eligible project costs
• you must complete your project by 30 June 2024

Ideally projects align with the National Strategic Action Plan for Childhood Heart Disease. Consider targeting the research priorities in the action plan, in particular:

• preventing neurodevelopmental and mental health complications
• understanding the impact of prenatal and postnatal factors affecting the health of children born with CHD and their families
• exploring the role of exercise and increased activity in reducing the impact of CHD

You must ensure new research is complementary to, and does not duplicate work in the following Medical Research Future Fund Accelerated Research investments:

• The Stem Cells Australia research study into development of human heart tissue for understanding heart disease, improving repair and reconstructing tissues for kids with heart defects.
• The Murdoch Children’s Research Institute project to enable the Australian Genomics Health Alliance to extend the Cardiovascular Genetic Disorders Flagship study. This looks at the genomic basis of disease in individuals and families with cardiomyopathies, arrhythmias and congenital heart disease.

The grant opportunity is closed to applications.

Reporting templates are available from the MRFF grants management webpage. The page also provides other resources for MRFF grant administration, including current policies and relevant forms and templates.